Compare RKDA & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKDA | EDVA |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Beverages (Production/Distribution) |
| Sector | Industrials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1M | 1.2M |
| IPO Year | 2015 | 2012 |
| Metric | RKDA | EDVA |
|---|---|---|
| Price | $0.27 | $0.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 11-06-2026 | 08-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.92 | 32.30 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,858,000.00 | $73,066.00 |
| Revenue This Year | $58.50 | $24,377.87 |
| Revenue Next Year | $475.01 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.25 | $0.16 |
| 52 Week High | $6.71 | $0.32 |
| Indicator | RKDA | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 25.30 | 17.39 |
| Support Level | N/A | $0.17 |
| Resistance Level | $0.78 | $0.30 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 4.65 | 3.85 |
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.